Ischemic Postconditioning Reduces Reperfusion Arrhythmias by Adenosine Receptors and Protein Kinase C Activation but Is Independent of KATP Channels or Connexin 43

• Published in: International journal of molecular sciences Vol. 20; no. 23; p. 5927
• Main Authors: Diez, Emiliano, Sánchez, Jose, Prado, Natalia, Ponce Zumino, Amira, García-Dorado, David, Miatello, Roberto, Rodríguez-Sinovas, Antonio
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 25-11-2019; MDPI
• Subjects: Action potential; Adenosine; Adenosine A3 receptors; Adenosine kinase; Cardiac arrhythmia; Channels; Chelerythrine; Connexin 32; Connexin 43; Delay; Drug dosages; Electrical impedance; Fibrillation; Glibenclamide; Heart attacks; Ischemia; Kinases; Potassium channels; Protein kinase C; Proteins; Receptor mechanisms; Reperfusion; Sinuses; Ventricle; Ventricular fibrillation
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms20235927

Ischemic postconditioning (IPoC) reduces reperfusion arrhythmias but the antiarrhythmic mechanisms remain unknown. The aim of this study was to analyze IPoC electrophysiological effects and the role played by adenosine A1, A2A and A3 receptors, protein kinase C, ATP-dependent potassium (KATP) channels, and connexin 43. IPoC reduced reperfusion arrhythmias (mainly sustained ventricular fibrillation) in isolated rat hearts, an effect associated with a transient delay in epicardial electrical activation, and with action potential shortening. Electrical impedance measurements and Lucifer-Yellow diffusion assays agreed with such activation delay. However, this delay persisted during IPoC in isolated mouse hearts in which connexin 43 was replaced by connexin 32 and in mice with conditional deletion of connexin 43. Adenosine A1, A2A and A3 receptor blockade antagonized the antiarrhythmic effect of IPoC and the associated action potential shortening, whereas exogenous adenosine reduced reperfusion arrhythmias and shortened action potential duration. Protein kinase C inhibition by chelerythrine abolished the protective effect of IPoC but did not modify the effects on action potential duration. On the other hand, glibenclamide, a KATP inhibitor, antagonized the action potential shortening but did not interfere with the antiarrhythmic effect. The antiarrhythmic mechanisms of IPoC involve adenosine receptor activation and are associated with action potential shortening. However, this action potential shortening is not essential for protection, as it persisted during protein kinase C inhibition, a maneuver that abolished IPoC protection. Furthermore, glibenclamide induced the opposite effects. In addition, IPoC delays electrical activation and electrical impedance recovery during reperfusion, but these effects are independent of connexin 43.